Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Hugh Grant backs social media healthcare site

August 7, 2009 Medical Communications, Sales and Marketing Digitial, patient information

The actor Hugh Grant is backing a new health advice website that encourages patients to share their experiences of illness. …
News

Vasella targeted by animal rights activists

August 6, 2009 Research and Development, Sales and Marketing Animal tests, Novartis, Vasella

Animal rights activists are believed to be behind two attacks on Novartis chief executive Daniel Vasella. The first attack came …
News

Afinitor approved in EU

August 6, 2009 Research and Development, Sales and Marketing Afinitor, Cancer, Europe, Novartis

Novartis’ new kidney cancer drug Afinitor (everolimus) has been approved in the EU for use when products such as Sutent …
News

US approval for Onglyza

August 6, 2009 Research and Development, Sales and Marketing AZ, BMA, diabetes

Adult type II diabetes treatment Onglyza has been approved by the US Food and Drug Administration. Co-marketed by AstraZeneca and …
News

Industry working group to look at UK digital marketing

August 6, 2009 Medical Communications, Sales and Marketing digi, pm society

The PM Society has set up an industry working group to bring some much-needed clarity to the uncharted waters of …
News

Boehringer’s lung cancer candidate enters phase III

August 5, 2009 Research and Development, Sales and Marketing Boehringer, Cancer

Boehringer Ingelheim is to enter phase III studies with a candidate to treat a subset of patients with non-small cell …
News

Centocor launches online arthritis talk show

August 4, 2009 Medical Communications, Sales and Marketing Centacor, RA, US, digi

An online talk show for rheumatoid arthritis patients has been launched in the US with the aim of raising awareness …
News

Avastin gets US approval in kidney cancer

August 4, 2009 Research and Development, Sales and Marketing Roche, US, avastin

Roche's rising star Avastin has won US approval to treat the most common type of kidney cancer, the latest in …
News

Crestor drives positive results for AZ

July 31, 2009 Sales and Marketing AZ, Crestor

AstraZeneca delivered a solid second quarter performance thanks to US delays to generic rivals and strong Crestor sales. The results …
News

Merck Serono asks EMEA to re-think Erbitux rejection

July 30, 2009 Research and Development, Sales and Marketing Cancer, EMEA, Erbitux, Europe, Merck Serono

Merck Serono is to appeal against the European rejection of Erbitux as a lung cancer treatment.Erbitux has been rejected as …
News

Sanofi makes bold promises with Q2 results

July 30, 2009 Sales and Marketing Sanofi-Aventis, patents

Sanofi-Aventis has promised its 2013 sales will at least match those the company made last year, despite facing huge and …
News

BMS profits surge ahead

July 30, 2009 Sales and Marketing BMS

Bristol Myers-Squibb's earnings growth massively outstripped its income in the second quarter of the year. The company saw its net …
News

Engaging with doctors online

July 29, 2009 Medical Communications, Sales and Marketing doctors, online communities

Digital marketing in all its forms can no longer be regarded the preserve of the 'early adopters' or young people …
Feature

Roche strengthened by swine flu

July 29, 2009 Sales and Marketing Roche

The effect of the swine flu pandemic has boosted Roche's half-year results, adding to figures already strengthened by the company's …
News

Genzyme cuts forecasts on production problems

July 29, 2009 Manufacturing and Production, Sales and Marketing Genzyme

The contamination problems at Genzyme's Allston Landing production plants have caused the firm to scale back its revenue forecasts for …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026